LiveWorld looks to increase its AI investmentCAMPBELL, Calif. and NEW YORK , May 08, 2025 (GLOBE NEWSWIRE) -- LiveWorld, Inc.…
- Dogwood Therapeutics, Inc. commenced dosing of patients in the Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Study - -…
The Independent Data Monitoring Committee (IDMC) has recommended to continue the study as planned as there are no safety concerns…
Commercial Cell & Gene therapy revenue of $7.2 million, up 33% year over yearQ1 2025 revenue from continuing operations of…
Voyles' appointment sets the stage for Imre's ability to deliver new solutions for healthcare clients navigating an era of rapid…
TEMPE, Ariz., May 7, 2025 /PRNewswire/ -- Economic activity in the hospital subsector grew in April for the 20th consecutive…
BEVERLY, Mass., May 7, 2025 /PRNewswire/ -- Tobin Scientific, a leading provider of cGMP storage, biorepository services, and specialized logistics for…
Study presented at DDW 2025 finds genetic risk scores can identify patients at higher risk of nausea from GLP-1 therapies,…
Eighth agency acquisition bolsters Supreme Group's ability to deliver agile, insight-driven creative solutions for the healthcare and life sciences industries…
Collaboration aims to enhance clinical study experience and accelerate therapeutic innovation for arrhythmogenic cardiomyopathy caused by PKP2 mutations SAN FRANCISCO…